# Cerba

> World\-class clinical research that helps life science companies to successfully develop the predictive and precision medicines of the future\.

Generated by Yoast SEO v28.1, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Project Management and Scientific Oversight](https://www.cerbaresearch.com/solutions/centralized-lab-management/project-management-and-scientific-oversight/)
- [Therapeutic Areas](https://www.cerbaresearch.com/therapeutic-areas/)
- [Infectious Diseases](https://www.cerbaresearch.com/therapeutic-areas/infectious-disease/)
- [Inflammation and Immunology](https://www.cerbaresearch.com/therapeutic-areas/inflammation-and-immunology/)
- [Spatial Omics](https://www.cerbaresearch.com/solutions/specialty-lab-testing/histopathology/spatial-omics/)

## Blogs
- [Flow Matters: Illuminating Immune Responses in Virology and Vaccine Testing](https://www.cerbaresearch.com/knowledge-center/blog/illuminating-immune-responses-in-virology-and-vaccine-testing/)
- [Flow Matters: Selecting the Right Reagents and Instruments for Flow Cytometry](https://www.cerbaresearch.com/knowledge-center/blog/seeing-in-full-color-selecting-the-right-reagents-and-instrumentation-for-your-flow-cytometry-assay/)
- [Combining Flow Cytometry, IHC \& NGS in Immuno\-oncology: Essential Trio for Biomarker Success](https://www.cerbaresearch.com/knowledge-center/blog/combining-flow-cytometry-ihc-ngs-in-immuno-oncology-essential-trio-for-biomarker-success/)
- [Flow Matters: The Power of Flow Cytometry in MRD Detection in Oncology](https://www.cerbaresearch.com/knowledge-center/blog/the-power-of-flow-cytometry-in-mrd-detection-in-oncology/)
- [Biomarker Assay\-Driven Clinical Trials](https://www.cerbaresearch.com/knowledge-center/blog/biomarker-assay-driven-clinical-trials/)

## Brochures
- [Highly Sensitive HPV Detection and Genotyping](https://www.cerbaresearch.com/brochure/highly-sensitive-hpv-detection-and-genotyping/)
- [Cerba Research’s Multi\-Omics Approaches in Hematological Malignancies](https://www.cerbaresearch.com/brochure/cerba-researchs-multi-omics-approaches-in-hematological-malignancies/)
- [Cerba Research Biorepository: Your Gateway to Rapid Specimen Procurement and Analysis](https://www.cerbaresearch.com/brochure/cerba-research-biorepository-your-gateway-to-rapid-specimen-procurement-and-analysis/)
- [Genomics Services at Cerba Research](https://www.cerbaresearch.com/brochure/genomics-services-at-cerba-research/)
- [Meeting the Challenges You Face with Global PBMC](https://www.cerbaresearch.com/brochure/meeting-the-challenges-you-face-with-global-pbmc-2/)

## Factsheets
- [Unlocking The Potential Of Rare Disease Drug Development](https://www.cerbaresearch.com/fact-sheet/unlocking-the-potential-of-rare-disease-drug-development/)
- [Advancing Cell \& Gene Therapy Trials With Confidence](https://www.cerbaresearch.com/fact-sheet/advancing-cell-gene-therapy-trials-with-confidence/)
- [Discover our Hematological Malignancies Trial Portfolio with Cutting\-Edge Laboratory Solutions](https://www.cerbaresearch.com/fact-sheet/discover-our-hematological-malignancies-trial-portfolio-with-cutting-edge-laboratory-solutions/)
- [Advancing Your Solid Tumor Trials With Our Cutting\-Edge Assay Portfolio](https://www.cerbaresearch.com/fact-sheet/advancing-your-solid-tumor-trials-with-our-cutting-edge-assay-portfolio/)
- [Unveiling the Oncology Journey: Highlighting cutting\-edge capabilities](https://www.cerbaresearch.com/fact-sheet/unveiling-the-oncology-journey-highlighting-cutting-edge-capabilities/)

## Flyers
- [Central Lab Division NASH Research](https://www.cerbaresearch.com/flyer/central-lab-division-nash-research/)
- [Processing Peripheral Blood Mononuclear Cells \(PBMC\) For Clinical Trials](https://www.cerbaresearch.com/flyer/processing-peripheral-blood-mononuclear-cells-pbmc-for-clinical-trials/)
- [Breast Cancer Biomarkers](https://www.cerbaresearch.com/flyer/breast-cancer-biomarkers/)
- [Lung Cancer Biomarkers](https://www.cerbaresearch.com/flyer/lung-cancer-biomarkers/)
- [Colorectal Cancer Biomarkers](https://www.cerbaresearch.com/flyer/colorectal-cancer-biomarkers/)

## Guides
- [A Best Practice Guide for Laboratory Services in Oncology Trials](https://www.cerbaresearch.com/guide/a-best-practice-guide-for-laboratory-services-in-oncology-trials/)

## Lists
- [Comprehensive view of our immunohistochemistry biomarkers](https://www.cerbaresearch.com/resource-list/comprehensive-view-of-our-immunohistochemistry-biomarkers/)
- [Off\-the\-Shelf 37\-plex MSD Panel](https://www.cerbaresearch.com/resource-list/off-the-shelf-37-plex-msd-panel/)

## News
- [Cerba Research Delivers Key Data for Clover’s Phase 1 RSV‑hMPV±PIV3 Combination Vaccines Study](https://www.cerbaresearch.com/news-events/news-articles/cerba-research-delivers-key-data-for-clovers-phase-1-rsv-hmpv±piv3-combination-vaccines-study/)
- [Cerba Research Launches Redesigned Website to Give Sponsors Quicker Access to Scientific Expertise](https://www.cerbaresearch.com/news-events/news-articles/cerba-research-launches-redesigned-website-to-give-sponsors-faster-access-to-scientific-expertise/)
- [Cerba Research Awarded NIH Contract for Central Lab Services](https://www.cerbaresearch.com/news-events/news-articles/cerba-research-awarded-nih-contract-for-central-lab-services/)

## Our Leadership
- [Lorella Di Donato](https://www.cerbaresearch.com/our-leadership/lorella-di-donato/)
- [Nele Langenaken](https://www.cerbaresearch.com/our-leadership/nele-langenaken/)
- [Charlotte Michel](https://www.cerbaresearch.com/our-leadership/charlotte-michel/)
- [Maria Fotiu](https://www.cerbaresearch.com/our-leadership/maria-fotiu/)
- [Teresa Dunlap](https://www.cerbaresearch.com/our-leadership/teresa-dunlap/)

## Posters
- [Clinical performance of three automated screening assays for antibodies against nuclear antigens](https://www.cerbaresearch.com/poster/clinical-performance-of-three-automated-screening-assays-for-antibodies-against-nuclear-antigens/)

## Press Release
- [Leveraging Medical Laboratory Data for Patient Recruitment](https://www.cerbaresearch.com/news-events/press-releases/leveraging-medical-laboratory-data-for-patient-recruitment/)
- [Cerba Research Announces Time‑Saving COVID‑19 Exploratory Tools and NGS Advancements](https://www.cerbaresearch.com/news-events/press-releases/cerba-research-announces-time-saving-covid-19-exploratory-tools-and-ngs-advancements/)
- [Cerba Research and Ozette Technologies Partnership](https://www.cerbaresearch.com/news-events/press-releases/cerba-research-and-ozette-technologies-partnership/)
- [Cerba HealthCare Acquires Viroclinics\-DDL](https://www.cerbaresearch.com/news-events/press-releases/cerba-healthcare-acquires-viroclinics-ddl-cerba-research/)
- [Viroclinics\-DDL Changes Name to Cerba Research](https://www.cerbaresearch.com/news-events/press-releases/viroclinics-ddl-changes-name-to-cerba-research/)

## Reports
- [Overcoming immunogenicity and safety assessment challenges for biologics and biosimilars in oncology](https://www.cerbaresearch.com/report/overcoming-immunogenicity-and-safety-assessment-challenges-for-biologics-and-biosimilars-in-oncology/)
- [Mitigating immunogenicity risks factors in AAV gene therapy clinical trials](https://www.cerbaresearch.com/report/mitigating-immunogenicity-risks-factors-in-aav-gene-therapy-clinical-trials/)
- [Infectious disease clinical trials: Navigating innovation \& rising complexity](https://www.cerbaresearch.com/report/infectious-disease-clinical-trials-navigating-innovation-rising-complexity/)

## Webinar
- [Overcoming Bioanalytical Challenges in Anti\-Drug Antibody Detection for ADCs](https://www.cerbaresearch.com/knowledge-center/webinar/overcoming-bioanalytical-challenges-in-anti-drug-antibody-detection-for-adcs/)
- [Analyzing Multiple Biomarkers with IHC: Putting a 6\-Plex Kit to the Challenge](https://www.cerbaresearch.com/knowledge-center/webinar/analyzing-multiple-biomarkers-with-ihc-putting-a-6-plex-kit-to-the-challenge/)
- [Immuno\-Oncology Biomarkers: From Exploratory Research to Trials](https://www.cerbaresearch.com/knowledge-center/webinar/immuno-oncology-biomarkers-research-to-trials/)
- [Advancing CAR T\-Cell Therapies with Clinical Trial Customization](https://www.cerbaresearch.com/knowledge-center/webinar/advancing-cart-t-cell-therapies-clinical-trial-customization/)

## Whitepapers
- [Immuno\-oncology Clinical Trials: Cerba Research \& Viroclinics\-DDL’s Synergistic Approach](https://www.cerbaresearch.com/knowledge-center/whitepaper/h1-white-paper-template/)
- [Overcoming Bioanalytical Challenges in Anti\-Drug Antibody Detection for Antibody\-Drug Conjugates \(ADCs\)](https://www.cerbaresearch.com/knowledge-center/whitepaper/overcoming-bioanalytical-challenges-in-anti-drug-antibody-detection-for-antibody-drug-conjugates/)
- [CAR\+T Drug Development: The Critical Role of Flow Cytometry](https://www.cerbaresearch.com/knowledge-center/whitepaper/cart-drug-development-the-critical-role-of-flow-cytometry/)
- [Decoding a T\-Cell Fingerprint](https://www.cerbaresearch.com/knowledge-center/whitepaper/decoding-a-t-cell-fingerprint/)
- [Decoding a B Cell Fingerprint](https://www.cerbaresearch.com/knowledge-center/whitepaper/decoding-a-b-cell-fingerprint-tcr-sequencing-2023-04_wp/)

## Content Type
- [Insight](https://www.cerbaresearch.com/content-type/insight/)
- [Event digest](https://www.cerbaresearch.com/content-type/event-digest/)
- [Interview](https://www.cerbaresearch.com/content-type/interview/)

## Services
- [Flow cytometry](https://www.cerbaresearch.com/services/flow-cytometry/)
- [Specialty lab testing](https://www.cerbaresearch.com/services/specialty-lab-testing/)
- [Assay development and technology transfer](https://www.cerbaresearch.com/services/assay-development-and-technology-transfer/)
- [Biomarkers](https://www.cerbaresearch.com/services/biomarkers/)
- [Next–generation sequencing](https://www.cerbaresearch.com/services/next-generation-sequencing/)

## Therapeutic Areas
- [Oncology](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=oncology)
- [Infectious diseases](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=infectious-diseases)
- [Immunooncology](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=immunooncology)
- [Cell and gene therapy](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=cell-and-gene-therapy)
- [Rare diseases](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=rare-diseases)

## Topics
- [Artificial Intelligence \(AI\)](https://www.cerbaresearch.com/topics/artificial-intelligence-ai/)
- [Partnership](https://www.cerbaresearch.com/topics/partnership/)
- [Global Footprint](https://www.cerbaresearch.com/topics/global-footprint/)
- [Automation](https://www.cerbaresearch.com/topics/automation/)
- [Operational Excellence](https://www.cerbaresearch.com/topics/operational-excellence/)

## Optional
- [Sitemap index](https://www.cerbaresearch.com/sitemap_index.xml)